After learning from these leaders, you will be able to:

1) Appraise the currently available blood-born biomarkers for diagnosis of mild brain injury; and,
2) Integrate new data on biomarkers for brain injury that are currently being researched and in development.

*Submission of the conference evaluation form indicates your completion of the entire program.

For tech support please click here.

Not seeing the content you were expecting during this livestream? Please double check the schedule to ensure that you’ve clicked on a session that is currently playing.